| View |
|
BR-1026
|
Laronidase
|
Aldurazyme
|
580 mcg/mL (2.9 mg/5 mL)
|
Concentrated Solution for IV Infusion
|
Prescription Drug (RX)
|
USP Type I clear and colorless glass vial (Box of 1's)
|
-
|
Biomarin Pharmaceutical Inc.
|
U.S.A
|
N/A
|
Sanofi-Aventis Philippines, Inc.
|
Sanofi-Aventis Philippines, Inc.
|
-
|
22 March 2022
|
29 September 2026
|
| View |
|
BR-1045
|
Idursulfase
|
Elaprase
|
6 mg/3 mL (2 mg/mL)
|
Concentrate for Solution for
Infusion (IV)
|
Prescription Drug (Rx)
|
Type I clear and colorless glass vial (Box of 1's)
|
Enzymes
|
Vetter Pharma-Fertigung GmbH & Co. KG
|
Germany
|
|
Sanofi-Aventis Philippines, Inc.
|
Sanofi-Aventis Philippines, Inc.
|
Renewal
|
20 March 2024
|
09 December 2028
|
| View |
|
BR-1046
|
Insulin Glulisine
|
Apidra
|
3.49 mg/mL (equivalent to 100 Units/mL)
|
Solution for Subcutaneous/Continuous SC Pump Infusion/
Intravenous Injection
|
Prescription Drug (RX)
|
10 mL Type I Colorless Glass Vial (Box of 1's)
|
-
|
Sanofi-Aventis Deutschland GmbH
|
Germany
|
|
Sanofi-Aventis Philippines, Inc.
|
Sanofi-Aventis Philippines, Inc.
|
-
|
26 February 2021
|
28 October 2025
|
| View |
|
BR-1048
|
Agalsidase Beta
|
Fabrazyme
|
35 mg
|
Powder for Concentrate for Solution for
Infusion (IV)
|
Prescription Drug (RX)
|
20 mL Type I glass vial with gray chlorobutyl stopper
and aluminum crimp seal (Box of 1's)
|
-
|
Genzyme Ireland Limited
|
Ireland
|
N/A
|
Sanofi-Aventis Philippines, Inc.
|
N/A
|
Renewal
|
21 November 2023
|
07 December 2028
|
| View |
|
BR-1049
|
Follitropin Alfa
|
Gonal-F
|
60 mg/0.6 mL 75 IU (5.5 mcg)
|
Lyophilized Powder for Solution for Subcutaneous Injection
|
Prescription Drug (RX)
|
Each box contains: Type I clear and colorless glass vial + diluent in pre-filled syringe (1 mL); 18G needle; 276 needle
|
-
|
Merck Serono SA
|
Switzerland
|
N/A
|
Merck, Inc.
|
Merck, Inc.
|
-
|
15 February 2022
|
09 February 2025
|
| View |
|
BR-1050
|
Cetuximab
|
Erbitux
|
5 mg/mL
|
Solution for Intravenous Infusion
|
Prescription Drug (RX)
|
EP Type I Glass Vial with Grey Flip-Off Cap x 20 mL (Box of 1's)
|
-
|
Merck Healthcare KGaA
|
Germany
|
N/A
|
Merck, Inc.
|
Merck, Inc.
|
-
|
01 September 2022
|
09 November 2024
|
| View |
BR-1051_PI_01.pdf
|
BR-1051
|
Basiliximab
|
Simulect
|
20 mg
|
Powder for Injection or Infusion (IV)
|
Prescription Drug (RX)
|
20mL vial + ampoule (Water for Injection as diluent) x 5 mL(Box of 1's)
|
-
|
Novartis Pharma Stein AG Technical Operations
|
Switzerland
|
N/A
|
Novartis Healthcare Philippines Inc.
|
Novartis Healthcare Philippines Inc.
|
|
02 November 2022
|
02 November 2027
|
| View |
|
BR-1053
|
Insulin Lispro (rDNA origin)
|
Humalog Kwikpen
|
100 units/mL
|
Solution for Injection (IM/IV/SC)
|
Prescription Drug (RX)
|
3 mL Type I pre-filled clear glass pen (Kwikpen] sealed with red halobutyl plunger at the bottom of the cartridge + bilayer elastomeric disc seal [Product contact layer: grey halobutyl and non-product contact layer: red isoprene] at the top (Box of 5's)
|
-
|
Eli Lilly Italia S.p.A.
|
Italy
|
N/A
|
Zuellig Pharma Corporation
|
N/A
|
Initial (Variation)
|
25 October 2022
|
25 October 2027
|
| View |
|
BR-1057
|
Insulin detemir
|
Levemir FlexPen
|
100 U/mL
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
3 mL solution in cartridge (Type I glass) with a plunger
(bromobutyl) and a stopper (bromobutyl/polyisoprene) contained in a pre-filled multidose disposable pen made of polypropylene (Box of 5's)
|
-
|
Novo Nordisk Producao Farmaceutica do Brasil Ltda.
|
Brazil
|
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
-
|
26 November 2021
|
18 March 2025
|
| View |
|
BR-1059
|
Somatropin
|
Scitropin A
|
5 mg/ 1.5 mL (15IU)
|
Solution S.C. for Injection
|
Prescription Drug (RX)
|
USP Type I Clear and Colourless Glass Cartridge x 1.5mL (Box of 1's and 2's)
|
Anterior Pituitary Lobe Hormone and Analogue
|
SANDOZ GmbH
|
Austria
|
|
Metro Drug, Inc.
|
Metro Drug, Inc.
|
Renewal
|
01 November 2023
|
27 November 2028
|
| View |
|
BR-1060
|
Epoetin Beta
|
Recormon
|
30000 IU/ 0.6 mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 ml Pre-filled Syringe with Needle (Box of 1's)
|
-
|
Roche Diagnostic GmbH
|
Germany
|
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
26 February 2021
|
03 December 2025
|
| View |
|
BR-1062
|
Epoetin Beta
|
Recormon
|
10,000 IU/0.6 mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL (Net content: 0.6 mL) Type I borosilicate glass syringe barrel with bromobutyl rubber plunger stopper bromobutyl rubber tip cap (Box of 6's)
|
-
|
Roche Diagnostics GmbH
|
Germany
|
N/A
|
Roche (Philippines), Inc.
|
Roche (Philippines), Inc.
|
Renewal
|
12 May 2023
|
17 March 2028
|
| View |
|
BR-1068
|
Trastuzumab
|
Herceptin
|
150 mg
|
Lyophilized Powder For Concentrate Solution For Infusion (IV)
|
Prescription Drug (RX)
|
Colourless glass vial (Box of 1's)
|
-
|
Genentech, Inc.
|
United States of America
|
F. Hoffmann-La Roche Ltd.
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Initial (Variation)
|
11 October 2022
|
11 October 2027
|
| View |
BR-1072_PI_01.pdf
|
BR-1072
|
Ranibizumab
|
Lucentis
|
10 mg/mL
|
Solution For Injection (Intravitreal)
|
Prescription Drug (RX)
|
2mL USP Type I Clear glass vial + CE-Marked medical device (5 µm filter needle) in a box
|
Antineovascular agents
|
Novartis Pharma Stein AG
|
Switzerland
|
|
Sandoz Philippines Corporation
|
|
Renewal
|
31 May 2024
|
29 May 2029
|
| View |
|
BR-1073
|
Filgrastim
|
Neubicyte
|
150 mcg/mL
|
Solution for Injection/ 150mg/ml
|
Prescription Drug (RX)
|
1ml
|
Hematopoietic Growth Factor
|
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
|
China
|
|
Endure Medical, Inc.
|
Endure Medical, Inc.
|
Renewal
|
20 June 2022
|
26 May 2027
|
| View |
|
BR-1074
|
Insulin Aspart
|
NovoRapid FlexPen
|
100 U/mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
3 mL Solution in a Cartridge (Type I Glass) with a Bromobutyl Plunger and a Bromobutyl/Polyisoprene Stopper contained in a Pre-filled Multidose Disposable Pen made of Polypropylene (Box of 5's)
|
-
|
Novo Nordisk Producao Farmaceutica do Brasil Ltda
|
Brazil
|
|
Novo Nordisk Pharmaceuticals (Phils.) Inc.
|
Novo Nordisk Pharmaceuticals (Phils.) Inc.
|
-
|
19 February 2021
|
20 March 2025
|
| View |
|
BR-1075
|
Brentuximab Vedotin
|
Adcetris
|
50 mg
|
Powder for Concentrate for Solution for IV Infusion
|
Prescription Drug (RX)
|
30 mL Type I clear glass vial with a butyl rubber stopper and an aluminum/plastic flip-off seal (Box of 1's)
|
-
|
BSP Pharmaceuticals S.p.A
|
Italy
|
Takeda Pharma A/S
|
Takeda Healthcare Philippines, Inc.
|
N/A
|
-
|
19 May 2021
|
01 April 2025
|
| View |
|
BR-1076
|
Heparin sodium (Bovine)
|
None
|
5, 000 IU/Ml
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
Type I Clear and Colorless Glass Vial x 5mL
|
-
|
Ain Medicare Sdn. Bhd.
|
Malaysia
|
|
Déga International Pharma Corp.
|
Déga International Pharma Corp.
|
-
|
24 August 2020
|
05 January 2025
|
| View |
|
BR-1077
|
Insulin Aspart
|
NovoMix 30 Flexpen
|
100 units per mL
|
Suspension for Injection (SC) (Formulation: 30% Soluble Insulin and 70% Protamine Insulin Aspart Crystals)
|
Prescription Drug (RX)
|
3 mL Pre-filled Pen (Cartridge: Type I Glass) with
Red Rubber Plunger, Type I Glass Bead and Cap with Rubber Closure (Box of 5's)
|
-
|
Novo Nordisk Producão Farmaceutica do Brasil Ltda
|
Brazil
|
|
Novo Nordisk Pharmaceuticals (Phils) Inc.
|
|
-
|
19 February 2021
|
27 April 2025
|
| View |
|
BR-1078
|
Trastuzumab
|
Herceptin
|
150 mg
|
Lyophilized Powder for Concentrate Solution for IV Infusion
|
Prescription Drug (RX)
|
15 mL Type I Glass Vial with Butyl Rubber Stopper
and Red Flip-off Cap (Box of 1’s)
|
Antineoplastic Agents
|
Roche Diagnostics GmbH
|
Germany
|
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Renewal
|
06 August 2024
|
11 November 2029
|